RT Journal Article
SR Electronic
T1 Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e008409
DO 10.1136/jitc-2023-008409
VO 12
IS 3
A1 Lenz, Heinz-Josef
A1 Parikh, Aparna
A1 Spigel, David R
A1 Cohn, Allen L
A1 Yoshino, Takayuki
A1 Kochenderfer, Mark
A1 Elez, Elena
A1 Shao, Spencer H
A1 Deming, Dustin
A1 Holdridge, Regan
A1 Larson, Timothy
A1 Chen, Eric
A1 Mahipal, Amit
A1 Ucar, Antonio
A1 Cullen, Dana
A1 Baskin-Bey, Edwina
A1 Kang, Tong
A1 Hammell, Amy B
A1 Yao, Jin
A1 Tabernero, Josep
YR 2024
UL http://jitc.bmj.com/content/12/3/e008409.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.